MERUS

Merus B.V., a biomedical company, engages in the discovery and development of antibody-based biopharmaceuticals. It develops Oligoclonics technology that offers a class of human antibodies, called Oligoclonics. Oligoclonics is a concept whereby a mixture of various human therapeutic antibodies, directed to a common antigen are produced from a single cell clone. The company was founded in 2003 and is based in Driebergen, the Netherlands.

#SimilarOrganizations #People #Financial #Event #Website #More

MERUS

Social Links:

Linkedin

Twitter

X

Industry:

Biotechnology Health Care Medical Therapeutics

Founded:

2003-01-01

Address:

Utrecht, Utrecht, The Netherlands

Country:

The Netherlands

Website Url:

http://www.merus.nl

Total Employee:

101+

Status:

Active

Contact:

31 30 253 8800

Email Addresses:

[email protected]

Total Funding:

288.84 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network

Similar Organizations

not_available_image

Actigen Ltd

Actigen Ltd is an biotechnology company engaged in the development of human antibody therapeutics.

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

allinky-biopharma-logo

Allinky Biopharma

Allinky Biopharma is a company dedicated to the discovery and development of novel therapeutic agents

morphosys-logo

MorphoSys

MorphoSys is a biotechnology company focused on the research and development of fully human antibodies.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

Current Advisors List

jack-nielsen_image

Jack Nielsen Board of Director @ Merus
Board_member

Current Employees Featured

anand-mehra_image

Anand Mehra
Anand Mehra Board Chair @ Merus
Board Chair
2020-06-01

shelley-margetson_image

Shelley Margetson
Shelley Margetson CFO @ Merus
CFO

john-de-kruif_image

John de Kruif
John de Kruif SVP and CTO @ Merus
SVP and CTO

ton-logtenberg_image

Ton Logtenberg
Ton Logtenberg Founder and CEO @ Merus
Founder and CEO

mark-throsby_image

Mark Throsby
Mark Throsby COO @ Merus
COO

lex-bakker_image

Lex Bakker
Lex Bakker Chief Development Officer and SVP @ Merus
Chief Development Officer and SVP
2010-10-01

peter-b-silverman_image

Peter B. Silverman
Peter B. Silverman EVP, General Counsel and Head of Utrecht @ Merus
EVP, General Counsel and Head of Utrecht

andrew-joe_image

Andrew Joe
Andrew Joe Chief Medical Officer @ Merus
Chief Medical Officer
2020-07-01

greg-perry_image

Greg Perry
Greg Perry Audit Committee Chairman @ Merus
Audit Committee Chairman
2016-05-01

mark-iwicki_image

Mark Iwicki
Mark Iwicki President of the Supervisory Board @ Merus
President of the Supervisory Board
2015-05-01

Founder

ton-logtenberg_image

Ton Logtenberg

Stock Details

Company's stock symbol is NASDAQ:MRUS

Investors List

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Post-IPO Equity - Merus

life-sciences-partners_image

Life Sciences Partners

Life Sciences Partners investment in Post-IPO Equity - Merus

biotechnology-value-fund_image

Biotechnology Value Fund

Biotechnology Value Fund investment in Post-IPO Equity - Merus

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series C - Merus

bay-city-capital_image

Bay City Capital

Bay City Capital investment in Series C - Merus

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series C - Merus

tekla-capital-management_image

Tekla Capital Management

Tekla Capital Management investment in Series C - Merus

johnson-johnson-innovation_image

Johnson & Johnson Innovation

Johnson & Johnson Innovation investment in Series C - Merus

life-sciences-partners_image

Life Sciences Partners

Life Sciences Partners investment in Series C - Merus

rock-springs-capital_image

Rock Springs Capital

Rock Springs Capital investment in Series C - Merus

Key Employee Changes

Date	New article
2020-07-27	Merus Appoints Andrew Joe, M.D., as Chief Medical Officer
2019-12-16	Merus Announces Chief Executive Officer Transition

Official Site Inspections

http://www.merus.nl Semrush global rank: 2.95 M Semrush visits lastest month: 5.51 K

Host Informations
Whois Informations

Loading ...

More informations about "Merus" on Search Engine